Contraception Development Research Center Program (P50 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The primary purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Research Development Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success. Additionally, it allows for behavioral and social science research projects to study contraceptive use and non-use of marketed products or products in clinical development.  The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research. 


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): January 6, 2021  ​

RFA-HD-21-011 Expiration Date January 7, 2021

Agency Website



Amount Description

A Center should propose a budget that reflects the actual needs of the proposed projects and costs; the budget must not exceed $1.3 million per year in direct costs, excluding third party F&A.

The scope of the proposed project should determine the project period. The maximum project period is 5 years. 

Funding Type





Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

January 6, 2021